Related references
Note: Only part of the references are listed.Guanosine boosts the fast, but not sustained, antidepressant-like and pro-synaptogenic effects of ketamine by stimulating mTORC1-driven signaling pathway
Anderson Camargo et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2022)
Prophylactic efficacy of ketamine, but not the low-trapping NMDA receptor antagonist AZD6765, against stress-induced maladaptive behavior and 4E-BP1-related synaptic protein synthesis impairment
Anderson Camargo et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2022)
The resilient phenotype elicited by ketamine against inflammatory stressors-induced depressive-like behavior is associated with NLRP3-driven signaling pathway
Anderson Camargo et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2021)
Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic
Damian F. Santomauro et al.
LANCET (2021)
A low-dose combination of ketamine and guanosine counteracts corticosterone-induced depressive-like behavior and hippocampal synaptic impairments via mTORC1 signaling
Anderson Camargo et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)
A single administration of ascorbic acid rapidly reverses depressive-like behavior and hippocampal synaptic dysfunction induced by corticosterone in mice
Daiane B. Fraga et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2021)
Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors
Vesna Lazarevic et al.
MOLECULAR PSYCHIATRY (2021)
Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin
Chadi G. Abdallah et al.
NEUROPSYCHOPHARMACOLOGY (2020)
A historical review of antidepressant effects of ketamine and its enantiomers
Yan Wei et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Ascorbic acid presents rapid behavioral and hippocampal synaptic plasticity effects
Daiane B. Fraga et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2020)
Guanosine fast onset antidepressant-like effects in the olfactory bulbectomy mice model
Roberto Farina de Almeida et al.
SCIENTIFIC REPORTS (2020)
Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine
Briana K. Chen et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Guanosine potentiates the antidepressant-like effect of subthreshold doses of ketamine: Possible role of pro-synaptogenic signaling pathway
Anderson Camargo et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Guanosine protects against behavioural and mitochondrial bioenergetic alterations after mild traumatic brain injury
Aline Alves Courtes et al.
BRAIN RESEARCH BULLETIN (2020)
Guanosine Promotes Proliferation in Neural Stem Cells from Hippocampus and Neurogenesis in Adult Mice
Tetsade C. B. Piermartiri et al.
MOLECULAR NEUROBIOLOGY (2020)
Involvement of adenosine A1 and A2A receptors on guanosine-mediated anti-tremor effects in reserpinized mice
C. M. Massari et al.
PURINERGIC SIGNALLING (2020)
Subthreshold doses of guanosine plus ketamine elicit antidepressant-like effect in a mouse model of depression induced by corticosterone: Role of GR/NF-κB/IDO-1 signaling
Anderson Camargo et al.
NEUROCHEMISTRY INTERNATIONAL (2020)
Guanosine modulates SUMO2/3-ylation in neurons and astrocytes via adenosine receptors
Camila A. Zanella et al.
PURINERGIC SIGNALLING (2020)
mTORC1-dependent signaling pathway underlies the rapid effect of creatine and ketamine in the novelty-suppressed feeding test
Francis L. Pazini et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
Ketamine, but not guanosine, as a prophylactic agent against corticosterone-induced depressive-like behavior: Possible role of long-lasting pro-synaptogenic signaling pathway
Anderson Camargo et al.
EXPERIMENTAL NEUROLOGY (2020)
Guanosine-Mediated Anxiolytic-Like Effect: Interplay with Adenosine A1 and A2A Receptors
Monica Frinchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Guanosine Attenuates Behavioral Deficits After Traumatic Brain Injury by Modulation of Adenosinergic Receptors
Fernando Dobrachinski et al.
MOLECULAR NEUROBIOLOGY (2019)
Lutein prevents corticosterone-induced depressive-like behavior in mice with the involvement of antioxidant and neuroprotective activities
Ana Lucia Bertarello Zeni et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
Lower synaptic density is associated with depression severity and network alterations
Sophie E. Holmes et al.
NATURE COMMUNICATIONS (2019)
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression A Randomized Clinical Trial
Ella J. Daly et al.
JAMA PSYCHIATRY (2019)
Augmentation effect of ketamine by guanosine in the novelty-suppressed feeding test is dependent on mTOR signaling pathway
Anderson Camargo et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2019)
Guanosine prevents oxidative damage and glutamate uptake impairment induced by oxygen/glucose deprivation in cortical astrocyte cultures: involvement of A1 and A2A adenosine receptors and PI3K, MEK, and PKC pathways
Tharine Dal-Cim et al.
PURINERGIC SIGNALLING (2019)
Guanosine prevents depressive-like behaviors in rats following bilateral dorsolateral striatum lesion induced by 6-hydroxydopamine
Naiani Ferreira Marques et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
Animal models of major depression: drawbacks and challenges
Barbara Planchez et al.
JOURNAL OF NEURAL TRANSMISSION (2019)
The antidepressant-like effect of guanosine is dependent on GSK-3β inhibition and activation of MAPK/ERK and Nrf2/heme oxygenase-1 signaling pathways
Priscila B. Rosa et al.
PURINERGIC SIGNALLING (2019)
Guanosine Protects Striatal Slices Against 6-OHDA-Induced Oxidative Damage, Mitochondrial Dysfunction, and ATP Depletion
Naiani Ferreira Marques et al.
NEUROTOXICITY RESEARCH (2019)
Adenosine A1-A2A Receptor-Receptor Interaction: Contribution to Guanosine-Mediated Effects
Debora Lanznaster et al.
CELLS (2019)
Ventral CA3 Activation Mediates Prophylactic Ketamine Efficacy Against Stress-Induced Depressive-like Behavior
Alessia Mastrodonato et al.
BIOLOGICAL PSYCHIATRY (2018)
Neuroprotective Effects of Guanosine Administration on In Vivo Cortical Focal Ischemia in Female and Male Wistar Rats
Luciele Varaschini Teixeira et al.
NEUROCHEMICAL RESEARCH (2018)
Prophylactic ketamine alters nucleotide and neurotransmitter metabolism in brain and plasma following stress
Josephine C. McGowan et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Panos Zanos et al.
PHARMACOLOGICAL REVIEWS (2018)
Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression A Randomized Clinical Trial
Ella J. Daly et al.
JAMA PSYCHIATRY (2018)
Single administration of agmatine reverses the depressive-like behavior induced by corticosterone in mice: Comparison with ketamine and fluoxetine
Vivian B. Neis et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2018)
Guanosine Anxiolytic-Like Effect Involves Adenosinergic and Glutamatergic Neurotransmitter Systems
Roberto Farina Almeida et al.
MOLECULAR NEUROBIOLOGY (2017)
Guanosine Protects Against Traumatic Brain Injury-Induced Functional Impairments and Neuronal Loss by Modulating Excitotoxicity, Mitochondrial Dysfunction, and Inflammation
Rogerio da Rosa Gerbatin et al.
MOLECULAR NEUROBIOLOGY (2017)
Guanosine Prevents Anhedonic-Like Behavior and Impairment in Hippocampal Glutamate Transport Following Amyloid-β1-40 Administration in Mice
Debora Lanznaster et al.
MOLECULAR NEUROBIOLOGY (2017)
Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder
Caio M. Massari et al.
FRONTIERS IN PHARMACOLOGY (2017)
Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway
Francis L. Pazini et al.
MOLECULAR NEUROBIOLOGY (2016)
Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression
Wen-Xue Liu et al.
PSYCHOPHARMACOLOGY (2016)
Intranasal guanosine administration presents a wide therapeutic time window to reduce brain damage induced by permanent ischemia in rats
Denise Barbosa Ramos et al.
PURINERGIC SIGNALLING (2016)
Ketamine use in current clinical practice
Mei Gao et al.
ACTA PHARMACOLOGICA SINICA (2016)
Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior
Rebecca A. Brachman et al.
BIOLOGICAL PSYCHIATRY (2016)
KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS
Chadi G. Abdallah et al.
DEPRESSION AND ANXIETY (2016)
The antidepressant-like effect of chronic guanosine treatment is associated with increased hippocampal neuronal differentiation
Luis E. B. Bettio et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2016)
Novel approaches for the management of depressive disorders
Manuella P. Kaster et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Reduced Global Functional Connectivity of the Medial Prefrontal Cortex in Major Depressive Disorder
James W. Murrough et al.
HUMAN BRAIN MAPPING (2016)
Zinc transporters protein level in postmortem brain of depressed subjects and suicide victims
Anna Rafalo-Ulinska et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2016)
Neuroprotection Promoted by Guanosine Depends on Glutamine Synthetase and Glutamate Transporters Activity in Hippocampal Slices Subjected to Oxygen/Glucose Deprivation
Tharine Dal-Cim et al.
NEUROTOXICITY RESEARCH (2016)
Purine metabolism is dysregulated in patients with major depressive disorder
Toni Ali-Sisto et al.
PSYCHONEUROENDOCRINOLOGY (2016)
Guanosine and its role in neuropathologies
Luis E. B. Bettio et al.
PURINERGIC SIGNALLING (2016)
Guanosine: a Neuromodulator with Therapeutic Potential in Brain Disorders
Debora Lanznaster et al.
AGING AND DISEASE (2016)
The Guanine-Based Purinergic System: The Tale of An Orphan Neuromodulation
Valentina Di Liberto et al.
FRONTIERS IN PHARMACOLOGY (2016)
Major depressive disorder
Christian Otte et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Ketamine as a promising prototype for a new generation of rapid-acting antidepressants
Chadi G. Abdallah et al.
TRANSLATIONAL NEUROSCIENCE IN PSYCHIATRY (2015)
Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder
G. I. Papakostas et al.
MOLECULAR PSYCHIATRY (2015)
Ketamine ameliorates depressive-like behaviors and immune alterations in adult rats following maternal deprivation
Gislaine Z. Reus et al.
NEUROSCIENCE LETTERS (2015)
Spine synapse remodeling in the pathophysiology and treatment of depression
Catharine H. Duman et al.
NEUROSCIENCE LETTERS (2015)
Guanosine inhibits LPS-induced pro-inflammatory response and oxidative stress in hippocampal astrocytes through the heme oxygenase-1 pathway
Bruna Bellaver et al.
PURINERGIC SIGNALLING (2015)
Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A1 and A2A receptor activation
Mauricio P. Cunha et al.
PURINERGIC SIGNALLING (2015)
Guanosine Protects Against Cortical Focal Ischemia. Involvement of Inflammatory Response
Gisele Hansel et al.
MOLECULAR NEUROBIOLOGY (2015)
The effects of chronic stress on hippocampal adult neurogenesis and dendritic plasticity are reversed by selective MAO-A inhibition
Monica Morais et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Guanosine prevents behavioral alterations in the forced swimming test and hippocampal oxidative damage induced by acute restraint stress
Luis E. B. Bettio et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
The hippocampal-prefrontal pathway: The weak link in psychiatric disorders?
Bill P. Godsil et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects
Vanja Duric et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Risk factors for suicide in individuals with depression: A systematic review
Keith Hawton et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions
Tharine Dal-Cim et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice
Yukio Ago et al.
NEUROPHARMACOLOGY (2013)
GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine
Rong-Jian Liu et al.
NEUROPSYCHOPHARMACOLOGY (2013)
NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice
Adam K. Walker et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Effects of ketamine and LY341495 on the depressive-like behavior of repeated corticosterone-injected rats
Hiroyuki Koike et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3K/mTOR pathways
Luis E. B. Bettio et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks
Brian Magnuson et al.
BIOCHEMICAL JOURNAL (2012)
Protective effects of guanosine against sepsis-induced damage in rat brain and cognitive impairment
Fabricia Petronilho et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Decreased expression of synapse-related genes and loss of synapses in major depressive disorder
Hyo Jung Kang et al.
NATURE MEDICINE (2012)
Signaling pathways underlying the rapid antidepressant actions of ketamine
Ronald S. Duman et al.
NEUROPHARMACOLOGY (2012)
Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
Nanxin Li et al.
BIOLOGICAL PSYCHIATRY (2011)
Evidence for the Existence of a Specific G Protein-Coupled Receptor Activated by Guanosine
Rosaria Volpini et al.
CHEMMEDCHEM (2011)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
GUANOSINE IS NEUROPROTECTIVE AGAINST OXYGEN/GLUCOSE DEPRIVATION IN HIPPOCAMPAL SLICES VIA LARGE CONDUCTANCE CA2+-ACTIVATED K+ CHANNELS, PHOSPHATIDILINOSITOL-3 KINASE/PROTEIN KINASE B PATHWAY ACTIVATION AND GLUTAMATE UPTAKE
T. Dal-Cim et al.
NEUROSCIENCE (2011)
The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder
Courtney S. Jernigan et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Mechanisms involved in the antinociception induced by systemic administration of guanosine in mice
A. P. Schmidt et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Rapid Resolution of Suicidal Ideation After a Single Infusion of an N-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
Nancy DiazGranados et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
CHRONIC FLUOXETINE TREATMENT INDUCES STRUCTURAL PLASTICITY AND SELECTIVE CHANGES IN GLUTAMATE RECEPTOR SUBUNITS IN THE RAT CEREBRAL CORTEX
E. Ampuero et al.
NEUROSCIENCE (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
Rebecca B. Price et al.
BIOLOGICAL PSYCHIATRY (2009)
Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/Depression
Denis J. David et al.
NEURON (2009)
Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression
Anteneh M. Feyissa et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Mechanism of guanosine-induced neuroprotection in rat hippocampal slices submitted to oxygen-glucose deprivation
Scheyla P. B. Oleskovicz et al.
NEUROCHEMISTRY INTERNATIONAL (2008)
Metabolism and distribution of guanosine given intraperitoneally: Implications for spinal cord injury
Shucui Jiang et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2008)
Proposal of a guanine-based purinergic system in the mammalian central nervous system
Andre P. Schmidt et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Characterization of guanine and guanosine transport in primary cultured rat cortical astrocytes and neurons
Kazuki Nagasawa et al.
GLIA (2007)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Amnesic effect of GMP depends on its conversion to guanosine
Jonas Alex Morales Saute et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2006)
Ketamine produces lasting disruptions in encoding of sensory stimuli
CR Maxwell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Nucleoside transporter expression and function in cultured mouse astrocytes
L Peng et al.
GLIA (2005)
Effects of chronic administered guanosine on behavioral parameters and brain glutamate uptake in rats
ER Vinade et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Oral administration of guanosine impairs inhibitory avoidance performance in rats and mice
ER Vinadé et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2004)
Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites
N Takei et al.
JOURNAL OF NEUROSCIENCE (2004)
Specific [3H]-guanosine binding sites in rat brain membranes
U Traversa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
